Work

Epidermal growth factor receptor targeted doxorubicin and vitexin loaded niosomes for enhanced breast cancer therapy

Year: 2023

Type: article

Abstract: NIODVC (cetuximab-conjugated doxorubicin and vitexin loaded niosome) proves effective for targeted breast cancer therapy. Enhanced cytotoxicity, cellular uptake, and gene downregulation show promise.

Source: Materials Advances

DOI: 10.1039/d3ma00328k

Authors: S. Malathi, Valappil Sisila, V. Singaravel, Nandakumar Venkatesan, Iqbal Pakrudheen, R. Dhanaraj, Niraikulam Ayyadurai, V. Bhuvarahamurthy, S. Narayana Kalkura

Institutions: Anna University, Chennai, Central Leather Research Institute, University of Madras, Universitat de València, Sri Ramachandra Institute of Higher Education and Research, CMR University

Language: English

Topic: Nanoparticle-Based Drug Delivery

Subfield: Biomaterials

Field: Materials Science

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,962

Funders: University of Madras, Council of Scientific and Industrial Research, India, University Grants Commission, Anna University, Bose Institute, Directorate for Biological Sciences

Awards: G316424740, G6411525300, G7877448667

OpenAlex ID: W4386901672

FWCI: 0.745

Cites: 69

Cited by: 13

Related to: 10